Your browser doesn't support javascript.
loading
iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapy.
Cichocki, Frank; Bjordahl, Ryan; Gaidarova, Svetlana; Mahmood, Sajid; Abujarour, Ramzey; Wang, Hongbo; Tuininga, Katie; Felices, Martin; Davis, Zachary B; Bendzick, Laura; Clarke, Raedun; Stokely, Laurel; Rogers, Paul; Ge, Moyar; Robinson, Megan; Rezner, Betsy; Robbins, David L; Lee, Tom T; Kaufman, Dan S; Blazar, Bruce R; Valamehr, Bahram; Miller, Jeffrey S.
Afiliación
  • Cichocki F; Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
  • Bjordahl R; Fate Therapeutics, San Diego, CA 92121, USA.
  • Gaidarova S; Fate Therapeutics, San Diego, CA 92121, USA.
  • Mahmood S; Fate Therapeutics, San Diego, CA 92121, USA.
  • Abujarour R; Fate Therapeutics, San Diego, CA 92121, USA.
  • Wang H; Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
  • Tuininga K; Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
  • Felices M; Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
  • Davis ZB; Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
  • Bendzick L; Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
  • Clarke R; Fate Therapeutics, San Diego, CA 92121, USA.
  • Stokely L; Fate Therapeutics, San Diego, CA 92121, USA.
  • Rogers P; Fate Therapeutics, San Diego, CA 92121, USA.
  • Ge M; Fate Therapeutics, San Diego, CA 92121, USA.
  • Robinson M; Fate Therapeutics, San Diego, CA 92121, USA.
  • Rezner B; Fate Therapeutics, San Diego, CA 92121, USA.
  • Robbins DL; Fate Therapeutics, San Diego, CA 92121, USA.
  • Lee TT; Fate Therapeutics, San Diego, CA 92121, USA.
  • Kaufman DS; Department of Medicine, Division of Regenerative Medicine, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
  • Blazar BR; Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA.
  • Valamehr B; Fate Therapeutics, San Diego, CA 92121, USA. mille011@umn.edu bob.valamehr@fatetherapeutics.com.
  • Miller JS; Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA. mille011@umn.edu bob.valamehr@fatetherapeutics.com.
Sci Transl Med ; 12(568)2020 11 04.
Article en En | MEDLINE | ID: mdl-33148626
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Madre Pluripotentes Inducidas / Neoplasias Límite: Humans Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Madre Pluripotentes Inducidas / Neoplasias Límite: Humans Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos